Gelonghui, November 29丨Guobang Pharmaceutical (605507.SH) announced that on November 29, 2024, the company received a “Notice Letter on the Results of Shareholding Reduction” issued by Zhejiang Minjin Investment Henghua and Silk Road Fund. As of November 29, 2024, Zhejiang Mintou Henghua and Silk Road Fund reduced their holdings of the company's shares by a total of 14,303,883 shares, accounting for 2.56% of the company's total share capital. The implementation of this holdings reduction plan has been completed.
国邦医药(605507.SH)：浙民投恒华、丝路基金累计减持2.56%股份
Guobang Pharmaceutical (605507.SH): Zhejiang Min Investment Henghua, Silk Road Fund have cumulatively reduced their shareholding by 2.56%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated